RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis
Titel:
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis
Auteur:
Klein, Allan L. Imazio, Massimo Brucato, Antonio Cremer, Paul LeWinter, Martin Abbate, Antonio Lin, David Martini, Alberto Beutler, Anna Chang, Steven Fang, Fang Gervais, Anais Perrin, Randy Paolini, John F.